# EDGAR Filing Document

**Accession Number:** 0001561921
**File Stem:** 0001104659-25-121648
**Filing Date:** 2025-12
**Character Count:** 2286
**Document Hash:** 5f930cdf5d8db9fd6e2547afdb58b180
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-121648.hdr.sgml**: 20260611

**ACCESSION NUMBER**: 0001104659-25-121648

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251216

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TELA Bio, Inc.
- **CENTRAL INDEX KEY:** 0001561921
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 455320061
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1 GREAT VALLEY PARKWAY, SUITE 24
- **CITY:** MALVERN
- **STATE:** PA
- **ZIP:** 19355
- **BUSINESS PHONE:** 484-320-2930

**MAIL ADDRESS:**
- **STREET 1:** 1 GREAT VALLEY PARKWAY, SUITE 24
- **CITY:** MALVERN
- **STATE:** PA
- **ZIP:** 19355

**TELA Bio, Inc.**

**1 Great Valley Parkway, Suite 24**

**Malvern, Pennsylvania 19355**

December 16, 2025

<u>VIA EDGAR</u>

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F Street, N.E.

Washington, D.C. 20549-7553

Re: TELA Bio, Inc.

Registration Statement on Form S-3<br> Filed December 12, 2025 (File No. 333-292090)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, TELA Bio, Inc. (the "***Company***") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-292090) (the "***Registration Statement***") be accelerated so that the Company's Registration Statement will become effective at 4:01 P.M., Eastern Time, on December 18, 2025, or as soon thereafter as is practicable.

Please contact Justin S. Platt, Esq. of Goodwin Procter LLP, counsel to the Company, at (212) 459-7340 to provide notice of effectiveness, or if you have any questions or comments concerning this request.

[*Remainder of the page intentionally left blank*]

---

| | | |
|:---|:---|:---|
| Very truly yours, | Very truly yours, | Very truly yours, |
| **TELA BIO, INC.** | **TELA BIO, INC.** | **TELA BIO, INC.** |
| By: | /s/ Antony Koblish | /s/ Antony Koblish |
|  | Name: | Antony Koblish |
|  | Title: | Chief Executive Officer |

---